Switch to:
Also traded in: Argentina, Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.13
CAH's Cash-to-Debt is ranked lower than
80% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.69 vs. CAH: 0.13 )
Ranked among companies with meaningful Cash-to-Debt only.
CAH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.42 Max: 3.34
Current: 0.13
0
3.34
Equity-to-Asset 0.18
CAH's Equity-to-Asset is ranked lower than
91% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.47 vs. CAH: 0.18 )
Ranked among companies with meaningful Equity-to-Asset only.
CAH' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.16  Med: 0.35 Max: 0.5
Current: 0.18
0.16
0.5
Debt-to-Equity 1.28
CAH's Debt-to-Equity is ranked lower than
84% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.53 vs. CAH: 1.28 )
Ranked among companies with meaningful Debt-to-Equity only.
CAH' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04  Med: 0.46 Max: 1.55
Current: 1.28
0.04
1.55
Debt-to-EBITDA 3.75
CAH's Debt-to-EBITDA is ranked lower than
76% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.37 vs. CAH: 3.75 )
Ranked among companies with meaningful Debt-to-EBITDA only.
CAH' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.24  Med: 1.74 Max: 3.75
Current: 3.75
0.24
3.75
Interest Coverage 6.07
CAH's Interest Coverage is ranked lower than
71% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.71 vs. CAH: 6.07 )
Ranked among companies with meaningful Interest Coverage only.
CAH' s Interest Coverage Range Over the Past 10 Years
Min: 5.89  Med: 11.51 Max: 15.33
Current: 6.07
5.89
15.33
Piotroski F-Score: 6
Altman Z-Score: 3.84
Beneish M-Score: -2.41
WACC vs ROIC
7.71%
17.81%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 1.29
CAH's Operating Margin % is ranked lower than
71% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.60 vs. CAH: 1.29 )
Ranked among companies with meaningful Operating Margin % only.
CAH' s Operating Margin % Range Over the Past 10 Years
Min: 0.99  Med: 1.61 Max: 2.11
Current: 1.29
0.99
2.11
Net Margin % 1.37
CAH's Net Margin % is ranked lower than
61% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.61 vs. CAH: 1.37 )
Ranked among companies with meaningful Net Margin % only.
CAH' s Net Margin % Range Over the Past 10 Years
Min: 0.33  Med: 1.08 Max: 1.49
Current: 1.37
0.33
1.49
ROE % 26.77
CAH's ROE % is ranked higher than
90% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.39 vs. CAH: 26.77 )
Ranked among companies with meaningful ROE % only.
CAH' s ROE % Range Over the Past 10 Years
Min: 5.47  Med: 17.46 Max: 26.77
Current: 26.77
5.47
26.77
ROA % 4.69
CAH's ROA % is ranked higher than
61% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.37 vs. CAH: 4.69 )
Ranked among companies with meaningful ROA % only.
CAH' s ROA % Range Over the Past 10 Years
Min: 1.33  Med: 4.46 Max: 5.58
Current: 4.69
1.33
5.58
ROC (Joel Greenblatt) % 48.63
CAH's ROC (Joel Greenblatt) % is ranked higher than
83% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 23.17 vs. CAH: 48.63 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
CAH' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 19.21  Med: 59.35 Max: 124.13
Current: 48.63
19.21
124.13
3-Year Revenue Growth Rate 15.40
CAH's 3-Year Revenue Growth Rate is ranked higher than
70% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.70 vs. CAH: 15.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CAH' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -4.7  Med: 13.5 Max: 43.9
Current: 15.4
-4.7
43.9
3-Year EBITDA Growth Rate 9.30
CAH's 3-Year EBITDA Growth Rate is ranked higher than
62% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 7.10 vs. CAH: 9.30 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
CAH' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -11.7  Med: 9.5 Max: 78.2
Current: 9.3
-11.7
78.2
3-Year EPS without NRI Growth Rate 6.10
CAH's 3-Year EPS without NRI Growth Rate is ranked lower than
56% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.10 vs. CAH: 6.10 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CAH' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -15.7  Med: 13.4 Max: 64.5
Current: 6.1
-15.7
64.5
GuruFocus has detected 2 Warning Signs with Cardinal Health Inc CAH.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CAH's 30-Y Financials

Financials (Next Earnings Date: 2018-05-01)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2017

CAH Guru Trades in Q1 2017

Richard Pzena 1,059,303 sh (New)
John Rogers 746,789 sh (+1944.54%)
Mairs and Power 2,981 sh (+3.11%)
John Buckingham 19,875 sh (+2.23%)
Seth Klarman 1,030,000 sh (unchged)
David Dreman Sold Out
Joel Greenblatt Sold Out
Paul Tudor Jones Sold Out
Scott Black Sold Out
Vanguard Health Care Fund 6,324,531 sh (-0.95%)
Arnold Van Den Berg 92,672 sh (-2.14%)
Barrow, Hanley, Mewhinney & Strauss 20,705,013 sh (-3.09%)
First Pacific Advisors 90,500 sh (-8.18%)
Ray Dalio 46,958 sh (-62.13%)
Pioneer Investments 55,347 sh (-82.81%)
» More
Q2 2017

CAH Guru Trades in Q2 2017

Manning & Napier Advisors, Inc 68,883 sh (New)
Charles Brandes 31,619 sh (New)
Steven Cohen 634,145 sh (New)
David Dreman 12,233 sh (New)
Seth Klarman 2,030,000 sh (+97.09%)
Vanguard Health Care Fund 7,522,531 sh (+18.94%)
Mairs and Power 3,434 sh (+15.20%)
John Buckingham 22,297 sh (+12.19%)
Barrow, Hanley, Mewhinney & Strauss 20,846,948 sh (+0.69%)
Pioneer Investments Sold Out
Ray Dalio Sold Out
Richard Pzena 1,058,804 sh (-0.05%)
Arnold Van Den Berg 91,167 sh (-1.62%)
John Rogers 661,475 sh (-11.42%)
First Pacific Advisors 52,300 sh (-42.21%)
» More
Q3 2017

CAH Guru Trades in Q3 2017

Paul Tudor Jones 8,145 sh (New)
Charles Brandes 698,546 sh (+2109.26%)
Richard Pzena 1,806,522 sh (+70.62%)
Steven Cohen 880,858 sh (+38.90%)
Seth Klarman 2,530,000 sh (+24.63%)
John Rogers 735,687 sh (+11.22%)
Vanguard Health Care Fund 7,865,646 sh (+4.56%)
Mairs and Power 3,434 sh (unchged)
David Dreman 12,233 sh (unchged)
Arnold Van Den Berg Sold Out
John Buckingham 21,487 sh (-3.63%)
Barrow, Hanley, Mewhinney & Strauss 20,051,896 sh (-3.81%)
Manning & Napier Advisors, Inc 63,515 sh (-7.79%)
First Pacific Advisors 43,000 sh (-17.78%)
» More
Q4 2017

CAH Guru Trades in Q4 2017

Pioneer Investments 1,827,056 sh (New)
Ray Dalio 475,692 sh (New)
Jim Simons 77,900 sh (New)
Larry Robbins 751,018 sh (New)
Joel Greenblatt 277,754 sh (New)
Seth Klarman 5,100,000 sh (+101.58%)
Charles Brandes 1,252,911 sh (+79.36%)
John Rogers 861,809 sh (+17.14%)
Richard Pzena 1,950,460 sh (+7.97%)
John Buckingham 22,478 sh (+4.61%)
Steven Cohen 51,400 sh (unchged)
First Pacific Advisors Sold Out
Paul Tudor Jones Sold Out
Mairs and Power 3,344 sh (-2.62%)
Vanguard Health Care Fund 7,572,246 sh (-3.73%)
Barrow, Hanley, Mewhinney & Strauss 17,876,233 sh (-10.85%)
Steven Cohen 316,500 sh (-64.07%)
David Dreman 590 sh (-95.18%)
» More
» Details

Insider Trades

Business Description

Industry: Medical Distribution » Medical Distribution    NAICS: 424210    SIC: 5122
Compare:NYSE:ABC, XKRX:091990, NAS:HSIC, HKSE:01099, NYSE:MCK, SHSE:601607, TSE:7459, SZSE:200028, SHSE:600056, NAS:PDCO, SZSE:002589, LSE:UDG, NYSE:PBH, NZSE:EBO, SHSE:600763, LSE:CLIN, SHSE:600090, NYSE:OMI, SHSE:603368, TSE:7476 » details
Traded in other countries:CAH.Argentina, CLH.Germany, CAH.Mexico,
Headquarter Location:USA
Cardinal Health Inc is a healthcare services company. It provides services and products for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices.

Cardinal Health is a major wholesaler of pharmaceuticals and medical supplies to pharmacies and hospitals. Its operations include procurement, packaging, inventory management, and logistics services. Its largest customer is CVS Health retail pharmacy operations.

Top Ranked Articles about Cardinal Health Inc

Seth Klarman Buys Time Warner, Boosts Pioneer, Allergan Guru's largest buys of the 4th quarter
Baupost Group's Seth Klarman (Trades, Portfolio) increased many holdings and established several positions in the fourth quarter. Read more...
Wall Street Falls Tuesday Morning Vipshop higher on revenue growth
U.S. market indexes were in the red Tuesday morning, with investors awaiting inflation data. Read more...
How to Generate Better Insight Ways to obtain different and improved understanding
I had the pleasure to sit down and discuss my value investing journey with a group of friends earlier this month. During the conversation, one of them asked this great question: “So how do you know that you have generated differentiated and better insight?” Read more...
Cardinal Health Adds Akhil Johri to its Board of Directors
Cardinal Health Board of Directors Approves Quarterly Dividend
Cardinal Health Announces Closing of Cardinal Health China Distribution Business Divestiture to Shanghai Pharma
Investor Expectations to Drive Momentum within Spark Energy, ScanSource, Brady, Cardinal Health, HP, and CSX — Discovering Underlying Factors of Influence
Cardinal Health to Webcast Discussion of Second-Quarter Results for Fiscal Year 2018 on February 8
Cardinal Health to Present at the 36th Annual J.P. Morgan Healthcare Conference
Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System

Ratios

vs
industry
vs
history
PE Ratio 11.97
NYSE:CAH's PE Ratio is ranked higher than
88% of the 57 Companies
in the Global Medical Distribution industry.

( Industry Median: 18.85 vs. NYSE:CAH: 11.97 )
Ranked among companies with meaningful PE Ratio only.
NYSE:CAH' s PE Ratio Range Over the Past 10 Years
Min: 6.29  Med: 15.93 Max: 73.78
Current: 11.97
6.29
73.78
Forward PE Ratio 13.64
NYSE:CAH's Forward PE Ratio is ranked higher than
53% of the 15 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.48 vs. NYSE:CAH: 13.64 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 11.97
NYSE:CAH's PE Ratio without NRI is ranked higher than
86% of the 57 Companies
in the Global Medical Distribution industry.

( Industry Median: 18.85 vs. NYSE:CAH: 11.97 )
Ranked among companies with meaningful PE Ratio without NRI only.
NYSE:CAH' s PE Ratio without NRI Range Over the Past 10 Years
Min: 9.98  Med: 18.82 Max: 74.54
Current: 11.97
9.98
74.54
Price-to-Owner-Earnings 18.89
NYSE:CAH's Price-to-Owner-Earnings is ranked lower than
51% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 18.18 vs. NYSE:CAH: 18.89 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
NYSE:CAH' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 6.22  Med: 14.66 Max: 58.55
Current: 18.89
6.22
58.55
PB Ratio 2.83
NYSE:CAH's PB Ratio is ranked lower than
66% of the 65 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.32 vs. NYSE:CAH: 2.83 )
Ranked among companies with meaningful PB Ratio only.
NYSE:CAH' s PB Ratio Range Over the Past 10 Years
Min: 0.86  Med: 2.53 Max: 4.76
Current: 2.83
0.86
4.76
PS Ratio 0.17
NYSE:CAH's PS Ratio is ranked higher than
88% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.88 vs. NYSE:CAH: 0.17 )
Ranked among companies with meaningful PS Ratio only.
NYSE:CAH' s PS Ratio Range Over the Past 10 Years
Min: 0.08  Med: 0.16 Max: 0.32
Current: 0.17
0.08
0.32
Price-to-Free-Cash-Flow 13.32
NYSE:CAH's Price-to-Free-Cash-Flow is ranked higher than
61% of the 33 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.77 vs. NYSE:CAH: 13.32 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
NYSE:CAH' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 5.82  Med: 12.08 Max: 43.13
Current: 13.32
5.82
43.13
Price-to-Operating-Cash-Flow 11.04
NYSE:CAH's Price-to-Operating-Cash-Flow is ranked higher than
60% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.21 vs. NYSE:CAH: 11.04 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
NYSE:CAH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 4.68  Med: 10.27 Max: 24.47
Current: 11.04
4.68
24.47
EV-to-EBIT 17.69
NYSE:CAH's EV-to-EBIT is ranked lower than
71% of the 70 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.77 vs. NYSE:CAH: 17.69 )
Ranked among companies with meaningful EV-to-EBIT only.
NYSE:CAH' s EV-to-EBIT Range Over the Past 10 Years
Min: 5.3  Med: 12 Max: 25.5
Current: 17.69
5.3
25.5
EV-to-EBITDA 11.61
NYSE:CAH's EV-to-EBITDA is ranked higher than
61% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.79 vs. NYSE:CAH: 11.61 )
Ranked among companies with meaningful EV-to-EBITDA only.
NYSE:CAH' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.5  Med: 9.7 Max: 17.6
Current: 11.61
4.5
17.6
EV-to-Revenue 0.23
NYSE:CAH's EV-to-Revenue is ranked higher than
81% of the 70 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.60 vs. NYSE:CAH: 0.23 )
Ranked among companies with meaningful EV-to-Revenue only.
NYSE:CAH' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.1  Med: 0.2 Max: 0.3
Current: 0.23
0.1
0.3
PEG Ratio 0.87
NYSE:CAH's PEG Ratio is ranked higher than
79% of the 29 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.47 vs. NYSE:CAH: 0.87 )
Ranked among companies with meaningful PEG Ratio only.
NYSE:CAH' s PEG Ratio Range Over the Past 10 Years
Min: 0.66  Med: 2.65 Max: 33.9
Current: 0.87
0.66
33.9
Shiller PE Ratio 19.84
NYSE:CAH's Shiller PE Ratio is ranked higher than
71% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: 29.39 vs. NYSE:CAH: 19.84 )
Ranked among companies with meaningful Shiller PE Ratio only.
NYSE:CAH' s Shiller PE Ratio Range Over the Past 10 Years
Min: 6.62  Med: 15.2 Max: 28.92
Current: 19.84
6.62
28.92
Current Ratio 1.09
NYSE:CAH's Current Ratio is ranked lower than
87% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.60 vs. NYSE:CAH: 1.09 )
Ranked among companies with meaningful Current Ratio only.
NYSE:CAH' s Current Ratio Range Over the Past 10 Years
Min: 1.06  Med: 1.53 Max: 2.99
Current: 1.09
1.06
2.99
Quick Ratio 0.57
NYSE:CAH's Quick Ratio is ranked lower than
93% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.12 vs. NYSE:CAH: 0.57 )
Ranked among companies with meaningful Quick Ratio only.
NYSE:CAH' s Quick Ratio Range Over the Past 10 Years
Min: 0.42  Med: 0.66 Max: 1.46
Current: 0.57
0.42
1.46
Days Inventory 34.29
NYSE:CAH's Days Inventory is ranked higher than
60% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 41.27 vs. NYSE:CAH: 34.29 )
Ranked among companies with meaningful Days Inventory only.
NYSE:CAH' s Days Inventory Range Over the Past 10 Years
Min: 25.37  Med: 30.84 Max: 35.34
Current: 34.29
25.37
35.34
Days Sales Outstanding 21.09
NYSE:CAH's Days Sales Outstanding is ranked higher than
94% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 61.26 vs. NYSE:CAH: 21.09 )
Ranked among companies with meaningful Days Sales Outstanding only.
NYSE:CAH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 19.16  Med: 21.73 Max: 23.22
Current: 21.09
19.16
23.22
Days Payable 55.72
NYSE:CAH's Days Payable is ranked lower than
63% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 62.55 vs. NYSE:CAH: 55.72 )
Ranked among companies with meaningful Days Payable only.
NYSE:CAH' s Days Payable Range Over the Past 10 Years
Min: 35.78  Med: 44.33 Max: 55.72
Current: 55.72
35.78
55.72

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 2.67
NYSE:CAH's Dividend Yield % is ranked higher than
71% of the 69 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.50 vs. NYSE:CAH: 2.67 )
Ranked among companies with meaningful Dividend Yield % only.
NYSE:CAH' s Dividend Yield % Range Over the Past 10 Years
Min: 0.67  Med: 1.99 Max: 3.23
Current: 2.67
0.67
3.23
Dividend Payout Ratio 0.32
NYSE:CAH's Dividend Payout Ratio is ranked higher than
91% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.28 vs. NYSE:CAH: 0.32 )
Ranked among companies with meaningful Dividend Payout Ratio only.
NYSE:CAH' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.22  Med: 0.37 Max: 1.12
Current: 0.32
0.22
1.12
3-Year Dividend Growth Rate 13.10
NYSE:CAH's 3-Year Dividend Growth Rate is ranked higher than
57% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.70 vs. NYSE:CAH: 13.10 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
NYSE:CAH' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 10.8  Med: 18.6 Max: 51.8
Current: 13.1
10.8
51.8
Forward Dividend Yield % 2.67
NYSE:CAH's Forward Dividend Yield % is ranked higher than
67% of the 66 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.79 vs. NYSE:CAH: 2.67 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 5.37
NYSE:CAH's 5-Year Yield-on-Cost % is ranked higher than
73% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.24 vs. NYSE:CAH: 5.37 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
NYSE:CAH' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.35  Med: 4 Max: 6.5
Current: 5.37
1.35
6.5
3-Year Average Share Buyback Ratio 2.10
NYSE:CAH's 3-Year Average Share Buyback Ratio is ranked higher than
88% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: -1.90 vs. NYSE:CAH: 2.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
NYSE:CAH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -38.9  Med: 0.6 Max: 5.7
Current: 2.1
-38.9
5.7

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 0.83
NYSE:CAH's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
79% of the 29 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.46 vs. NYSE:CAH: 0.83 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
NYSE:CAH' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.3  Med: 1.33 Max: 8.9
Current: 0.83
0.3
8.9
Price-to-Intrinsic-Value-DCF (Earnings Based) 0.96
NYSE:CAH's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
62% of the 13 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.97 vs. NYSE:CAH: 0.96 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
NYSE:CAH' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.38  Med: 0.68 Max: 1.56
Current: 0.96
0.38
1.56
Price-to-Median-PS-Value 1.03
NYSE:CAH's Price-to-Median-PS-Value is ranked lower than
62% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.90 vs. NYSE:CAH: 1.03 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
NYSE:CAH' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.52  Med: 1.48 Max: 3.38
Current: 1.03
0.52
3.38
Price-to-Peter-Lynch-Fair-Value 0.77
NYSE:CAH's Price-to-Peter-Lynch-Fair-Value is ranked higher than
83% of the 18 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.31 vs. NYSE:CAH: 0.77 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
NYSE:CAH' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.49  Med: 1.33 Max: 11.86
Current: 0.77
0.49
11.86
Earnings Yield (Greenblatt) % 5.64
NYSE:CAH's Earnings Yield (Greenblatt) % is ranked lower than
68% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 7.10 vs. NYSE:CAH: 5.64 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
NYSE:CAH' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 3.9  Med: 8.3 Max: 19
Current: 5.64
3.9
19
Forward Rate of Return (Yacktman) % 23.81
NYSE:CAH's Forward Rate of Return (Yacktman) % is ranked higher than
82% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.62 vs. NYSE:CAH: 23.81 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
NYSE:CAH' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 4  Med: 10.6 Max: 25.8
Current: 23.81
4
25.8

More Statistics

Revenue (TTM) (Mil) $132,614.00
EPS (TTM) $ 5.75
Beta1.17
Short Percentage of Float3.44%
52-Week Range $54.66 - 84.88
Shares Outstanding (Mil)314.71

Analyst Estimate

Jun18 Jun19 Jun20
Revenue (Mil $) 136,768 142,158 146,491
EBIT (Mil $) 2,559 2,708 3,218
EBITDA (Mil $) 3,333 3,491 4,026
EPS ($) 4.98 5.54 6.06
EPS without NRI ($) 4.98 5.54 6.06
EPS Growth Rate
(Future 3Y To 5Y Estimate)
16.77%
Dividends per Share ($) 1.62 1.63 1.42

Piotroski F-Score Details

Piotroski F-Score: 66
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyN
Higher Current Ratio yoyN
Less Shares Outstanding yoyY
Higher Gross Margin yoyY
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}